拟被复星医药超5亿增持的复宏汉霖,想在海外市场大展拳脚

第一财经
21 Apr

复星医药(600196.SH、02196.HK)私有化复宏汉霖(02696.HK)计划没有成行后,拟改为增持后者股份。4月21日晚间,复星医药发布公告称,基于对复宏汉霖发展的信心及价值的认可,2025年4月11日至4月17日期间,控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别达成转让协议,拟以港币24.60元/股的价格受让该等卖方持有的合计2103.43万股复宏汉霖非上市...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10